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Background: Coronary artery disease (CAD) is often present with severe aortic stenosis (AS). We aimed to identify the prevalence and clinical 
significance of CAD and its relation to calcificationseverity or degree of aortic valve stenosis.
Methods: 364 high-risk patients (pts) with severe AS who were referred to participate in a trial of trans-catheter aortic valve implantation were 
included. Pts were studied based on their CAD -- normal coronaries, non obstructive CAD (< 50% stenosis), and significant CAD ( ≥50% stenosis).
Results: Angiographic findings detected normal coronaries in 50 (13.7%), non-significant CAD in 90 (24.7%), and significant CAD in 224 (61.5%). 
Significant CAD was common in pts with higher STS/EuroSCORE and cardiac risk factors and with lower ejection fraction. (Table) There was no 
correlation between significant CAD and aortic valve area (r=0.1, p=0.06). The mortality rate was 121 (33.2%) during median follow up 343.5 [157-
619.7] days. There was no difference in mortality rate among the 3 groups. There was significant correlation between the presence of significant CAD 
and aortic valve calcification (r=0.3, p<0.001).
Conclusion: The prevalence of significant CAD among pts with severe AS is high (~60%) and correlates with the degree of calcification but not 
with the degree of stenosis. The presence of significant CAD does have an impact on clinical outcome, which may allow for treating the AS first and 
deferment of coronary intervention in this high-risk group. 
Normal CAD
N=50
Non-significant CAD
N=90
Significant CAD
N=224
P value
Age (years) 79.2±10.4 81.7±9.1 81.7±7.5 0.1
Female (%) 38 (76) 60 (66.6) 105 (46.8) <0.001
Hyperlpidemia (%) 26 (53.1) 57 (63.3) 182 (82) <0.001
Smoking (%) 12 (24.5) 12 (13.3) 66 (29.4) 0.01
PVD (%) 11 (22.4) 22 (24.7) 82 (36.6) 0.03
STS score (%) 10.3±5.5 10.8±5.4 12.3±6.8 0.05
Logistic EuroSCORE (%) 27.2±18.6 31.6±18.3 43.1±23.4 <0.001
Ejection fraction (%) 55.2±15.9 54.5±15.6 46.2±17.4 <0.001
Mortality (%) 16 (32) 29 (32.2) 76 (33.9) 0.9
